Results 71 to 80 of about 132,140 (136)

Samidorphan sadness: does the addition of samidorphan to olanzapine have prodepressive effects? [PDF]

Int Clin Psychopharmacol
Parkerson JA, Chaia AI, Lynch ST, Sterchele AN.   +3 more
europepmc   +1 more source

Prescribing to protect case series: naltrexone as a novel intervention to prevent fentanyl overdose in people who use cocaine. [PDF]

Addict Sci Clin Pract
Xue R, Alves J, Baldwin M, Zhang J, Labelle C, Walley AY.   +5 more
europepmc   +1 more source

Overcoming barriers to the prescription/dispensation of take-home naloxone among French primary care professionals: a regional training initiative. [PDF]

Eur J Public Health
Aquizerate A, Duval M, Rousselet M, Jaulin E, Kuhn E, Oger AC, Nicolleau I, Pele S, Herault T, Artarit P, Laforgue EJ, Victorri-Vigneau C.   +11 more
europepmc   +1 more source

Oxytocin attenuates respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl in rats. [PDF]

Biomed Pharmacother
Escobar JB, Wainwright J, Wang X, Dergacheva O, Kay MW, Bethea JR, Jain V, Polotsky VY, Mendelowitz D.   +8 more
europepmc   +1 more source

Multicentre, double-blind, randomised, placebo-controlled study on the prophylactic use of naldemedine for opioid-induced nausea and vomiting in patients with cancer (POSEIDON study): a protocol paper. [PDF]

BMJ Open
Ishihara Y, Ohira M, Hokabe M, Yoshino S, Iwashita K, Takahashi K, Tomita N, Uneno Y, Kataoka S, Kurihashi T, Satomi E, Hamano J, Higashibata T, Kosugi K, Hirakawa M, Kajiura S, Ogihara S, Kida M, Morita T, Koretaka Y, Sonoyama T, Oyamada S, Nakajima A, Kessoku T.   +23 more
europepmc   +1 more source

Executive summary of the guideline for prescribing opioid analgesics for chronic non-cancer pain (third edition) by the Japan Society of Pain Clinicians. [PDF]

J Anesth
Kanai A, Iseki M, Iida H, Yamaguchi S, Oiwa A, Yonekura H, Iwashita N, Ueno H, Kimura Y, Takasusuki T, Yamaguchi K, Iida S, Ikemiya H, Oya R, Sugiyama Y, Tanabe K, Taniguchi A, Hattammaru Y, Mizogami M, Yamaguchi S, Yamada K, Fukui S.   +21 more
europepmc   +1 more source

Development of a nalmefene formulation suitable for a community-use auto-injector. [PDF]

Br J Clin Pharmacol
Cipriano A, Shet MS, Huang H, Ortiz R, Whiteside GT, Apseloff G, Harris SC.   +6 more
europepmc   +1 more source

Extended-release buprenorphine in adults with opioid use disorder involving poppy seed tea: An 18-month retrospective case series. [PDF]

Am J Addict
McMaster J, Seshakumaran S, Abeysundera H, Tipirneni I, Hormiz R.   +4 more
europepmc   +1 more source

Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism. [PDF]

West J Emerg Med
Warren O, Gress J, Lin T, Lippmann M, Bubly G.   +4 more
europepmc   +1 more source

Patient Insights to Improve Naloxone Access and Decision Support. [PDF]

Perm J
Boraz R, Stumbo SP, Leitz SJ, Yarborough BJH.   +3 more
europepmc   +1 more source